Concurrent Investment Advisors LLC Buys 361 Shares of Lam Research Corporation $LRCX

Concurrent Investment Advisors LLC lifted its stake in Lam Research Corporation (NASDAQ:LRCX) by 2.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 16,090 shares of the semiconductor company’s stock after buying an additional 361 shares during the period. Concurrent Investment Advisors LLC’s holdings in Lam Research were worth $1,566,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in LRCX. BankPlus Wealth Management LLC raised its holdings in shares of Lam Research by 2.0% in the 2nd quarter. BankPlus Wealth Management LLC now owns 5,248 shares of the semiconductor company’s stock valued at $511,000 after purchasing an additional 105 shares during the period. ORG Partners LLC raised its holdings in Lam Research by 7.3% in the 2nd quarter. ORG Partners LLC now owns 1,676 shares of the semiconductor company’s stock valued at $162,000 after acquiring an additional 114 shares during the period. Fairvoy Private Wealth LLC raised its holdings in Lam Research by 3.0% in the 2nd quarter. Fairvoy Private Wealth LLC now owns 4,185 shares of the semiconductor company’s stock valued at $407,000 after acquiring an additional 120 shares during the period. Abundance Wealth Counselors raised its holdings in Lam Research by 1.1% in the 2nd quarter. Abundance Wealth Counselors now owns 11,537 shares of the semiconductor company’s stock valued at $1,123,000 after acquiring an additional 124 shares during the period. Finally, First Pacific Financial raised its holdings in Lam Research by 7.7% in the 2nd quarter. First Pacific Financial now owns 1,766 shares of the semiconductor company’s stock valued at $172,000 after acquiring an additional 126 shares during the period. Institutional investors own 84.61% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on LRCX. Morgan Stanley set a $125.00 price target on shares of Lam Research and gave the company an “equal weight” rating in a report on Monday, September 22nd. Argus increased their price target on shares of Lam Research from $105.00 to $120.00 and gave the company a “buy” rating in a report on Friday, August 1st. Citigroup increased their target price on shares of Lam Research from $113.00 to $120.00 and gave the stock a “buy” rating in a research report on Monday, September 8th. Wells Fargo & Company increased their target price on shares of Lam Research from $98.00 to $135.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 2nd. Finally, Rothschild & Co Redburn increased their target price on shares of Lam Research from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Tuesday. Twenty-three investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $123.80.

Lam Research Stock Performance

Shares of NASDAQ:LRCX opened at $144.78 on Thursday. The company’s 50 day simple moving average is $117.40 and its 200 day simple moving average is $95.82. The stock has a market capitalization of $182.57 billion, a price-to-earnings ratio of 34.80, a price-to-earnings-growth ratio of 1.68 and a beta of 1.84. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $153.70.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.12. The business had revenue of $5.17 billion for the quarter, compared to analysts’ expectations of $4.99 billion. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The firm’s quarterly revenue was up 33.6% compared to the same quarter last year. During the same period last year, the firm posted $1.03 earnings per share. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. As a group, research analysts predict that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th were paid a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. This is a positive change from Lam Research’s previous quarterly dividend of $0.23. The ex-dividend date of this dividend was Wednesday, September 24th. Lam Research’s payout ratio is 25.00%.

Insider Transactions at Lam Research

In related news, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the transaction, the senior vice president directly owned 251,047 shares of the company’s stock, valued at $34,870,428.30. This trade represents a 17.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.31% of the stock is owned by company insiders.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.